Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 104 M96 M99 M83 M109 M107 M 398 M Research & development —————— — Operating income 44 M85 M89 M139 M65 M105 M 398 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 21 M22 M21 M22 M21 M22 M 86 M Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 42 M96 M102 M153 M77 M116 M 448 M Equity in earnings —————— — Taxes 11 M23 M23 M35 M18 M27 M 103 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 31 M73 M79 M118 M59 M89 M 345 M Discontinued operations —————— — Net income 31 M73 M79 M118 M59 M89 M 345 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 31 M73 M79 M118 M59 M89 M 345 M Basic earnings per share (Basic EPS) 0.150.350.380.550.280.42 1.63 Diluted earnings per share (Diluted EPS) 0.150.350.380.550.280.42 1.63 Average basic shares outstanding 210.3 M210.3 M210.3 M210.3 M210.6 M210.7 M — Diluted shares outstanding 210.3 M210.3 M210.4 M210.4 M211.8 M211.9 M — EBITDA 85 M130 M135 M182 M98 M— — EBIT 53 M97 M100 M147 M65 M105 M 417 M Cost of revenue 629 M712 M698 M768 M670 M699 M 2.83 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 32 M33 M35 M35 M33 M— —